Michael Geffner Immunovant, Inc. (IMVT) insider trading activity

Michael Geffner is Chief Medical Officer of Immunovant, Inc.. Currently has a direct ownership of 225,370 shares of IMVT, which is worth approximately $6.2 Million. The most recent transaction as insider was on Apr 23, 2025, when has been sold 2,349 shares (Common Stock) at a price of $14.79 per share, resulting in proceeds of $34,741. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 225K

70.33% 3M change

59.14% 12M change

Total Value Held $6.2 Million

Michael Geffner Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Apr 23 2025	SELL Open market or private sale	$34,741 $14.79 p/Share	2,349 Reduced 1.03%	225,370 Common Stock
Apr 01 2025	BUY Grant, award, or other acquisition	-	101,574 Added 30.28%	233,888 Common Stock
Jan 22 2025	SELL Open market or private sale	$62,678 $23.59 p/Share	2,657 Reduced 1.97%	132,314 Common Stock
Oct 23 2024	SELL Open market or private sale	$94,171 $29.53 p/Share	3,189 Reduced 2.31%	134,971 Common Stock
Jul 24 2024	SELL Open market or private sale	$95,938 $27.76 p/Share	3,456 Reduced 2.44%	138,160 Common Stock
Apr 24 2024	SELL Open market or private sale	$94,242 $28.9 p/Share	3,261 Reduced 2.25%	141,616 Common Stock
Apr 02 2024	BUY Grant, award, or other acquisition	-	54,978 Added 27.51%	144,877 Common Stock
Jan 26 2024	SELL Open market or private sale	$385,656 $38.18 p/Share	10,101 Reduced 10.1%	89,899 Common Stock

Michael Geffner

Chief Medical Officer

New York, NY

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells IMVT shares.

Notify only if

Value

Insider Trading

Get notified when an Immunovant, Inc. insider buys or sells IMVT shares.

Notify only if

Operation

Value

Type

News

Receive news related to Immunovant, Inc.

Track Activities on IMVT

Account